COVID-19对肾细胞癌患者治疗的影响

Q3 Veterinary
Archives of Razi Institute Pub Date : 2024-10-31 eCollection Date: 2024-10-01 DOI:10.32592/ARI.2024.79.5.1091
R B Nerli, S Gautam, S C Ghagane, S Rai
{"title":"COVID-19对肾细胞癌患者治疗的影响","authors":"R B Nerli, S Gautam, S C Ghagane, S Rai","doi":"10.32592/ARI.2024.79.5.1091","DOIUrl":null,"url":null,"abstract":"<p><p>Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The current pandemic has resulted in a significant reallocation of health-care resources, with the recommended treatment strategy advocating for oncology patients was to delay elective procedures. A retrospective analysis was conducted to evaluatethe impact of COVID-19 on patients with renal cell carcinoma (RCC) and the associated treatment protocols. A retrospective review of the inpatient and outpatient records of all patients presenting with renal cell carcinoma during the period from March 2020 to the end of March 2021 was conducted. A total of 26 patients (21 males and 5 females) with a mean age of 55.46±9.44 years were diagnosed with an operable renal mass during the study period. The mean hospitalisation period (15.19±2.28) was found to be longer in patients who required surgical intervention. The delay was attributable to a number of factors, including the necessity for pre-operative testing using RT-PCR, a chest HR-CT, clearance from the chest physician, and preparation. The overall cost of hospitalization increased in these patients compared to the pre-pandemic period due to a number of factors, including prolonged hospitalization, an increased incidence of complications, the necessity for pre-operative testing for SARS-CoV-2, the use of personal protective equipment, and the provision of nursing care. During the same period, three out of eight patients who had metastatic disease with positive RT-PCR were initiated on targeted therapy, while the remaining underwent cytoreductive nephrectomy. The study concludes that patients with RCC seeking treatment during the current pandemic face significant challenges, including delays in treatment, increased hospitalization rates, and a rise in testing, which collectively contribute to elevated treatment costs. It is imperative to conduct a long-term follow-up to ascertain whether these factors have influenced the outcome of the patients in question.</p>","PeriodicalId":8311,"journal":{"name":"Archives of Razi Institute","volume":"79 5","pages":"1091-1097"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12018751/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of COVID-19 on Treatment in Patients with Renal Cell Carcinoma.\",\"authors\":\"R B Nerli, S Gautam, S C Ghagane, S Rai\",\"doi\":\"10.32592/ARI.2024.79.5.1091\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The current pandemic has resulted in a significant reallocation of health-care resources, with the recommended treatment strategy advocating for oncology patients was to delay elective procedures. A retrospective analysis was conducted to evaluatethe impact of COVID-19 on patients with renal cell carcinoma (RCC) and the associated treatment protocols. A retrospective review of the inpatient and outpatient records of all patients presenting with renal cell carcinoma during the period from March 2020 to the end of March 2021 was conducted. A total of 26 patients (21 males and 5 females) with a mean age of 55.46±9.44 years were diagnosed with an operable renal mass during the study period. The mean hospitalisation period (15.19±2.28) was found to be longer in patients who required surgical intervention. The delay was attributable to a number of factors, including the necessity for pre-operative testing using RT-PCR, a chest HR-CT, clearance from the chest physician, and preparation. The overall cost of hospitalization increased in these patients compared to the pre-pandemic period due to a number of factors, including prolonged hospitalization, an increased incidence of complications, the necessity for pre-operative testing for SARS-CoV-2, the use of personal protective equipment, and the provision of nursing care. During the same period, three out of eight patients who had metastatic disease with positive RT-PCR were initiated on targeted therapy, while the remaining underwent cytoreductive nephrectomy. The study concludes that patients with RCC seeking treatment during the current pandemic face significant challenges, including delays in treatment, increased hospitalization rates, and a rise in testing, which collectively contribute to elevated treatment costs. It is imperative to conduct a long-term follow-up to ascertain whether these factors have influenced the outcome of the patients in question.</p>\",\"PeriodicalId\":8311,\"journal\":{\"name\":\"Archives of Razi Institute\",\"volume\":\"79 5\",\"pages\":\"1091-1097\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12018751/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Razi Institute\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32592/ARI.2024.79.5.1091\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Veterinary\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Razi Institute","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32592/ARI.2024.79.5.1091","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Veterinary","Score":null,"Total":0}
引用次数: 0

摘要

2019冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒-2 (SARS-CoV-2)引起的。当前的大流行已导致卫生保健资源的重大重新分配,倡导肿瘤患者的建议治疗战略是推迟选择性手术。回顾性分析COVID-19对肾细胞癌(RCC)患者的影响及相关治疗方案。回顾性分析了2020年3月至2021年3月底期间所有肾细胞癌患者的住院和门诊记录。共26例患者(男21例,女5例),平均年龄55.46±9.44岁,诊断为可手术肾肿块。需要手术治疗的患者平均住院时间(15.19±2.28)更长。延迟可归因于许多因素,包括术前使用RT-PCR检测的必要性,胸部HR-CT,胸部医生的许可和准备。由于许多因素,包括住院时间延长、并发症发生率增加、术前检测SARS-CoV-2的必要性、使用个人防护装备以及提供护理,这些患者的住院总费用比大流行前有所增加。在同一时期,8例RT-PCR阳性的转移性疾病患者中有3例开始了靶向治疗,其余患者接受了细胞减减性肾切除术。该研究的结论是,在当前大流行期间寻求治疗的RCC患者面临重大挑战,包括治疗延误、住院率上升和检测增加,这些因素共同导致治疗费用上升。有必要进行长期随访,以确定这些因素是否影响了患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of COVID-19 on Treatment in Patients with Renal Cell Carcinoma.

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The current pandemic has resulted in a significant reallocation of health-care resources, with the recommended treatment strategy advocating for oncology patients was to delay elective procedures. A retrospective analysis was conducted to evaluatethe impact of COVID-19 on patients with renal cell carcinoma (RCC) and the associated treatment protocols. A retrospective review of the inpatient and outpatient records of all patients presenting with renal cell carcinoma during the period from March 2020 to the end of March 2021 was conducted. A total of 26 patients (21 males and 5 females) with a mean age of 55.46±9.44 years were diagnosed with an operable renal mass during the study period. The mean hospitalisation period (15.19±2.28) was found to be longer in patients who required surgical intervention. The delay was attributable to a number of factors, including the necessity for pre-operative testing using RT-PCR, a chest HR-CT, clearance from the chest physician, and preparation. The overall cost of hospitalization increased in these patients compared to the pre-pandemic period due to a number of factors, including prolonged hospitalization, an increased incidence of complications, the necessity for pre-operative testing for SARS-CoV-2, the use of personal protective equipment, and the provision of nursing care. During the same period, three out of eight patients who had metastatic disease with positive RT-PCR were initiated on targeted therapy, while the remaining underwent cytoreductive nephrectomy. The study concludes that patients with RCC seeking treatment during the current pandemic face significant challenges, including delays in treatment, increased hospitalization rates, and a rise in testing, which collectively contribute to elevated treatment costs. It is imperative to conduct a long-term follow-up to ascertain whether these factors have influenced the outcome of the patients in question.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Archives of Razi Institute
Archives of Razi Institute Veterinary-Veterinary (all)
CiteScore
1.50
自引率
0.00%
发文量
108
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信